Home » Newsletters » BioWorld Science

BioWorld Science

May 31, 2005

View Archived Issues

17-DMAG induces cytostasis in testicular teratocarcinoma cells

Atorvastatin shows potential as a chemopreventive agent

ED-B targeted therapy L19-IL2 effective in pancreatic cancer model

In vivo and in vitro data on ZP-120 reported

Bristol-Myers Squibb profiles Q1 developments

NDA submitted for indiplon tablets

Santarus submits Zegerid chewable tablets NDA

Second clinical study completed for E-Matrix

Data demonstrates wound healing effects of TB4

Myogen and Novartis expand cardiac drug discovery collaboration

Discovery and antitumor efficacy of ABT-737, a Bcl-2 blocker

Antitumor and antiangiogenic effects of the class III/V tyrosine kinase inhibitor SU-11657 in mice

IC-486051: a novel PDE4 inhibitor for overactive bladder treatment

Novel PDE4 inhibitor/M3 antagonist evaluated in preclinical models of COPD

JPM7 induces strong and fast rabbit tracheal muscle relaxation

Uracyst launched in U.K.

New approval for Arixtra

Vivitrex NDA accepted for priority review

Long-term benefits of Cypher stents in patients with coronary artery disease

Zemplar capsules receive FDA approval

Promising alternative to injectable anthrax vaccine

Additional data on efficacy of exenatide in patients with type 2 diabetes

Role of interleukin-13 in the pathogenesis of eosinophilic esophagitis

Flavonoid derivative suppresses NF-kappaB activation in human colonic epithelial cells

Alnylam and U of Georgia to develop RNAi therapeutic for flu

In vivo data on kallikreins in ovarian cancer reported by Ibex

Ablynx and NRC to develop Nanobodies for CNS diseases

New urological agents reported

New treatment option for anxiety and depression claimed by Roche

Recent Kosan patents cover therapeutic agents for gastric motility disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...